Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Guardant Health GH Resistance Levels Guardant Health Inc posts 386 negative EPS miss vs estimates What Uniti Group UNIT disclosed about cost pressures Uniti Group Plunges on Massive Loss Miss What Autodesk ADSK management is not saying enough about 261 20260508 Jobless Claims Hold Near Historic Lows Signaling Ongoing Labor Market Resilience UK Exports to US Plunge 25 as Trump Tariffs Create Trade Deficit With Largest Partner Federal Reserve May Struggle to Justify Interest Rate Cuts as Inflation Concerns Persist Energy Utilities Roundup Market Talk Highlights Sector Dynamics UK Police Chiefs Call for Social Media Block on Under16s Over Safety Risks Gold Pullback Highlights Rising Rates as Dominant Factor Over SafeHaven Demand RDN Q1 2026 Earnings EPS Beat Sends Stock Lower Despite Positive Surprise ALAB Q1 2026 Earnings EPS Surprises with 1164 Beat Shares Rally Cango Inc Q4 2025 Earnings Deep EPS Miss Triggers Stock Decline CBOE Q1 2026 Earnings EPS Surges Past Estimates with 1028 Beat ATRA Q1 2026 Earnings Loss Narrows More Than Expected Amid Ongoing Pipeline Progress VMD Q1 2026 Earnings EPS Misses Estimates by 34 Amid Uncertain Revenue Outlook Penske Automotive Group PAG Finds Support Posts Modest Gain Invesco Quality Municipal Income Trust IQI Edges Higher Tests Key Resistance BIOkey International BKYI Declines 44 as Selling Pressure Persists Near Key Support Dave Inc Warrants DAVEW Surge Over 22 as Momentum Builds Cohen Circle Acquisition Corp II CCII Holds Steady Near 1025 Amid SPAC Trading Range Maiden Holdings MHLA Q3 2024 Earnings Net Loss Persists Despite Flat Revenue Environment Note Price Edges Higher Vaxcyte Q1 2026 Earnings EPS Misses Estimates Amid PreCommercial Investment Phase Cyngn Inc CYN Q1 2026 Earnings EPS Beat Amid Zero Revenue Stock Edges Lower McKesson MCK Q1 2026 Earnings EPS Slightly Beats Estimates Stock Holds Steady AIM ImmunoTech Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues RD Investment TaskUs TASK Q1 2026 Earnings EPS Slightly Misses Estimates Amid Modest Revenue Headwinds